Latest Strategy Changes News

Page 747 of 935
North Stawell Minerals Ltd reported a significant reduction in cash reserves for the quarter ending March 2025, highlighting a potential capital raising as exploration activities near completion.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.
Ada Torres
Ada Torres
30 Apr 2025
Hydrix Limited reports improved operating performance in Q3 FY25, buoyed by FDA clearance of its Gyder Surgical Hip Navigation system and a reduced cash operating loss, while managing tight liquidity with shareholder support.
Ada Torres
Ada Torres
30 Apr 2025
Eneco Refresh Limited reports solid 8% year-to-date revenue growth for Q3 FY2025, underpinned by gains in its water and plastics segments and improved cash flow.
Victor Sage
Victor Sage
30 Apr 2025
Empire Energy Group reported significant cash outflows in Q1 2025 driven by exploration and infrastructure investments but bolstered its liquidity with new financing facilities, including a Midstream Infrastructure Facility for the Carpentaria Gas Plant.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Elixinol Wellness reported a 13.7% year-on-year revenue increase in Q1 FY25, despite a softer quarter compared to record Q4, with ecommerce momentum and strategic initiatives setting the stage for margin recovery and growth in H2.
Victor Sage
Victor Sage
30 Apr 2025
The Star Entertainment Group reported a 9% revenue decline to $271 million in Q3 FY25 alongside a $21 million EBITDA loss, driven by seasonal factors and operational challenges. The company is advancing strategic investments and joint venture exits amid ongoing liquidity pressures and regulatory hurdles.
Victor Sage
Victor Sage
30 Apr 2025
Avecho Biotechnology has inked a decade-long exclusive licensing agreement with Sandoz for its pharmaceutical-grade cannabidiol capsule targeting insomnia in Australia, backed by a US$3 million upfront payment and promising milestone and royalty streams.
Victor Sage
Victor Sage
30 Apr 2025
Vonex Limited has appointed Michael Blake as CEO while completing a $13.9 million entitlement offer and refinancing its debt, reinforcing its operational and financial foundation. The company also earned recognition for industry-leading complaint resolution.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Codeifai Limited reports a robust 141% increase in Q1 2025 cash receipts, driven by its revamped Digital First Engagement First strategy and the expanding ConnectQR SaaS platform. Despite rising costs, the company maintains strong margins and is strategically reviewing its Material Science division.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Cullen Resources Limited reported significant progress in its gold exploration portfolio for the March 2025 quarter, including exercising an option to acquire 90% of the Yardilla Project and planning extensive drilling campaigns across multiple joint ventures.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Vintage Energy reported a dip in quarterly sales and production but achieved cost savings and secured a key permit renewal, positioning itself for a production uplift program despite recent flooding delays.
Maxwell Dee
Maxwell Dee
30 Apr 2025